Xinjiang Baihuacun Pharam Tech Co. Ltd. Class A

Xinjiang Baihuacun Pharam Tech Co. Ltd. Class A

SSSE:600721
8.41
CNY
-0.48
(-5.40%)
0.06EPS
202.93P/E
5.04BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
4.61
4.46
3.23
2.64
1.05
1.05
0.66
0.22
0.75
0.93
0.97
1.01
1.01
0.83
Basic EPS, GAAP
0.01
-0.94
-1.62
0.49
-1.41
-1.69
0.09
-0.82
0.16
-0.09
0.03
0.11
0.11
0.06
Free Cash Flow per Basic Share
-0.66
0.46
1.37
-0.52
-0.26
0.06
-0.08
-0.07
0.08
0.14
0.12
0.15
0.03
- -
Dividend per Share
0.58
0.45
0.39
0.06
0.01
- -
- -
- -
- -
- -
- -
- -
- -
0.04
Book Value per Share
3.66
2.75
1.34
6.55
4.3
2.28
2.35
1.65
1.82
1.77
1.85
1.98
2.09
2.09
Tangible Book Value per Share
1.62
0.71
-0.28
1.61
1.56
1.81
1.92
1.59
1.75
1.7
1.77
1.85
1.95
1.97
Basic Weighted Avg Shares
268
249
250
282
400
400
400
390
375
376
379
382
384
384
Sales/Revenue/Turnover
1,235
1,109
809
745
420
419
262
85
281
350
369
386
388
320
Operating Margin (%)
12.07
-16.48
-33.02
-12.91
16.39
30.82
21.57
-247.46
29.52
8.13
18.62
24.03
20.12
11.84
Depreciation Expense
204
168
170
105
19
27
30
30
25
26
23
19
19
- -
Net Income, GAAP
2
-234
-406
139
-564
-675
34
-320
60
-35
13
41
41
25
Effective Tax Rate (%)
75.47
- -
- -
43.13
- -
- -
19.74
- -
3.7
- -
21.29
- -
7.87
- -
Profit Margin (%)
0.17
-21.07
-50.2
18.69
-134.47
-161.09
13.12
-378.28
21.26
-9.94
3.51
10.75
10.48
7.75
Working Capital
-1,421
-1,782
-2,261
291
272
332
314
132
214
216
256
274
319
315
LT Debt
440
210
76
22
17
12
29
- -
- -
2
1
- -
- -
- -
Total Equity
1,371
997
455
2,298
1,733
919
939
624
686
667
707
759
802
803
Return on Invested Capital (%)
-0.12
- -
- -
3
- -
- -
2.42
- -
9.31
- -
2.06
- -
5.47
- -
Return on Capital (%)
0.99
- -
- -
16.63
- -
- -
3.71
- -
9.09
- -
1.88
- -
5.21
- -
Return on Common Equity (%)
0.22
-27.1
-75.71
10.63
-28.16
-51.26
3.71
-41.03
9.2
-5.16
1.89
5.66
5.21
- -

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
20
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
385
385
385
Market Capitalization
3,915
2,546
5,041

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
556
524
545
Cash, Cash Equivalents & STI
293
265
279
Accounts Receivable, Net
120
128
132
Inventories
30
27
35
Total Current Liabilities
235
215
230
Payables & Accruals
- -
- -
- -
ST Debt
20
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
32.83%
5.23%
5.7%
Free Cash Flow
-73.86%
-38.84%
-77.69%
Net Income, GAAP
-195.14%
-39.26%
-1.91%
Sales/Revenue/Turnover
11.1%
53.57%
0.66%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
91
105
94
95
386
2025
97
105
- -
90
388
2026
67
90
73
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.01
- -
0.05
0.11
2025
0.05
0.01
- -
0.02
0.11
2026
0.02
0.02
0.01
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
0.04
- -
- -
- -

Company Description

CEO
Hui Huang
Full Time Employees
672
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
No. 1, South Alley Urumqi XI China 830002
IPO Date
Jun 26, 1996
Website
xjbhc.net
Business
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd operates primarily in comprehensive pharmaceutical services, encompassing the development and registration of small molecule chemicals and peptide-based drugs. The company’s core activities span early-stage drug discovery, clinical investigations, biological sample analysis, and medicine testing. Furthermore, it engages in providing active pharmaceutical ingredients, intermediate supplies, and related technology services, alongside its involvement in property leasing. Formed in 1959, the enterprise is headquartered in Urumqi, China.